All

Results: 34657-34668 of 56716

Enzymatica's Board of Directors updates the financial targets

NEJM publishes ALTUVOCT® phase 3 XTEND-Kids results highlighting treatment potential for children with severe haemophilia A

Notice of Extraordinary General Meeting in Enzymatica AB (publ)

PR Newswire associated0

SM INVESTMENTS LISTS USD 500 MILLION DEBT NOTES ON SINGAPORE EXCHANGE

Enzymatica's Board of Directors decides on a new rights issue of approximately SEK 130 million

PR Newswire associated0

Hyundai Mobis Unveils World's First Innovative Airbags for PBVs

PR Newswire associated0

Paris Olympics offers bounty of opportunities for cybercriminals and fraudsters

PR Newswire associated0

Case Packing Systems gets to market faster with smarter machines and the FactoryTalk® Optix™ platform

SKF interim report Q2 2024: Margin resilience in continued soft markets

Save the date: Essity's Capital Markets Day, December 3, 2024

EQT AB (publ) Half-year Report 2024

Hansa Biopharma Reports Second Quarter 2024 Financial Results and Business Update